carbapenems has been researched along with Hematologic Malignancies in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (7.14) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 15 (53.57) | 24.3611 |
2020's | 11 (39.29) | 2.80 |
Authors | Studies |
---|---|
Chen, H; Jiang, Y; Qu, T; Shi, W; Wang, J; Wang, N; Yang, Q; Zhang, P | 1 |
Bomers, MK; de Jonge, NA; de la Court, JR; Heijmans, J; Lambregts, MMC; Schade, RP; Schoffelen, AF; Sigaloff, KCE; van der Bruggen, T; Woudt, SHS | 1 |
Chen, J; Cui, Y; Huang, X; Ma, H; Ma, S; Niu, R; Pan, P; Peng, W; Rao, M; Su, L; Yang, H; Zhang, P; Zhu, F | 1 |
Caruso, P; Del Missier, GM; Junior, APN; Praça, APA; Silva, ILAFE | 1 |
Gopakumar, KG; Jithin, TK; Nair, C; Nirmal, G; Parthiban, R | 1 |
He, Y; Hu, H; Liu, D; Song, J; Yang, J; Zhu, X; Zou, S | 1 |
Margolis, E; Wolf, J | 1 |
Boutin, S; Dalpke, AH; Heeg, K; Kocer, K; Mutters, NT; Nurjadi, D | 1 |
Butler, AM; Ford, CD; Forsyth, S; Healy, R; Hoda, D; Jones, PB; Lopansri, BK; Majers, J; Snow, G; Webb, BJ | 1 |
Akazawa, M; Fukuda, H; Mimura, W | 1 |
Heo, BY; Jo, DY; Kwon, J; Lee, HJ; Lee, MW; Ryu, H; Song, IC; Yeon, SH; Yun, HJ | 1 |
Alp, E; Çetin, M; Elmali, F; Kaynar, L; Kürkçüoglu, CA; Metan, G; Yozgat, N | 1 |
Daikos, GL; Kosmidis, C; Kotsopoulou, M; Pantazatou, A; Perlorentzou, S; Piperaki, ET; Poulli, A; Samarkos, M; Tofas, P; Triantafyllopoulou, ID; Vagia, M | 1 |
Cho, SY; Chung, DR; Ha, YE; Huh, K; Kang, CI; Kim, SH; Lee, NY; Peck, KR; Seok, H; Song, JH | 1 |
Boucher, HW; Johnson, K | 1 |
Jenkins, SG; Satlin, MJ; Walsh, TJ | 1 |
Bassetti, M; Botti, S; Ciceri, F; Cudillo, L; Errico, A; Farina, C; Giannella, M; Girmenia, C; Locatelli, F; Lombardini, L; Luzzaro, F; Majolino, I; Piciocchi, A; Rambaldi, A; Rossolini, GM; Sarmati, L; Tascini, C; Viscoli, C | 1 |
Angebault, C; Bourhis, JH; Chachaty, E; de Botton, S; Gachot, B; Micol, JB; Pasquier, F; Pilorge, S; Woerther, PL | 1 |
Andria, N; Domchenko, A; Fraser, D; Henig, O; Kotler, O; Ofran, Y; Oren, I; Paul, M; Zuckerman, T | 1 |
Askin, G; Chen, L; Cohen, N; Gedrimaite, Z; Kreiswirth, BN; Ma, KC; Satlin, MJ; Seo, SK; Soave, R; Walsh, TJ | 1 |
Aversa, F; Busca, A; Candoni, A; Cattaneo, C; Del Principe, MI; Delia, M; Di Blasi, R; Fanci, R; Fianchi, L; Lessi, F; Martino, B; Melillo, L; Nadali, G; Pagano, L; Perriello, V; Sica, S; Trecarichi, EM; Tumbarello, M | 1 |
Ballarò, D; Bucaneve, G; Capria, S; Cartoni, C; Foà, R; Gentile, G; Grammatico, S; Micozzi, A; Minotti, C; Pacetti, E; Santilli, S | 1 |
Basso, M; Costa, SF; Dulley, FL; Fonseca, GH; Fu, L; Guimarães, T; Levin, AS; Paez, J; Rossi, F | 1 |
Ichiyama, S; Igawa, J; Iinuma, Y; Kondo, T; Matsushima, A; Nagao, M; Saito, T; Takakura, S; Takaori-Kondo, A; Yamashita, K | 1 |
Ichikawa, M; Kurokawa, M; Nannya, Y; Narukawa, K; Toya, T | 1 |
Calfee, DP; Chen, L; Fauntleroy, KA; Feldman, EJ; Helfgott, DC; Jenkins, SG; Kreiswirth, BN; Roboz, GJ; Satlin, MJ; Shore, TB; Soave, R; Walsh, TJ; Wilson, SJ | 1 |
Suppola, JP; Vaara, M; Valtonen, VV; Volin, L | 1 |
Cometta, A; Glauser, MP | 1 |
1 review(s) available for carbapenems and Hematologic Malignancies
Article | Year |
---|---|
Empiric antibiotic monotherapy with carbapenems in febrile neutropenia: a review.
Topics: Anti-Bacterial Agents; Carbapenems; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Meropenem; Neutropenia; Randomized Controlled Trials as Topic; Thienamycins | 1996 |
1 trial(s) available for carbapenems and Hematologic Malignancies
Article | Year |
---|---|
A comparative analysis of meropenem and doripenem in febrile patients with hematologic malignancies: a single-center retrospective study.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Doripenem; Female; Fever; Hematologic Neoplasms; Humans; Male; Meropenem; Middle Aged; Retrospective Studies; Risk Factors; Thienamycins; Treatment Outcome | 2012 |
26 other study(ies) available for carbapenems and Hematologic Malignancies
Article | Year |
---|---|
In vivo acquisition of bla
Topics: Anti-Bacterial Agents; Carbapenems; Hematologic Neoplasms; Humans; Klebsiella pneumoniae; Pseudomonas aeruginosa | 2022 |
Third-generation cephalosporin resistant gram-negative bacteraemia in patients with haematological malignancy; an 11-year multi-centre retrospective study.
Topics: Bacteremia; Carbapenems; Ceftazidime; Hematologic Neoplasms; Humans; Prospective Studies; Retrospective Studies | 2022 |
Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
Topics: Adult; Bacteremia; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; China; Hematologic Neoplasms; Humans; Klebsiella pneumoniae; Retrospective Studies; Risk Factors; Sepsis; Shock, Septic; Tertiary Care Centers | 2022 |
In-hospital mortality and one-year survival of critically ill patients with cancer colonized or not with carbapenem-resistant gram-negative bacteria or vancomycin-resistant enterococci: an observational study.
Topics: Adult; Carbapenems; Critical Illness; Gram-Negative Bacteria; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Hospital Mortality; Humans; Vancomycin-Resistant Enterococci | 2023 |
Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Child; Female; Hematologic Neoplasms; Humans; Klebsiella Infections; Male; Neutropenia; Prevalence; Retrospective Studies; Shock, Septic | 2023 |
CRO infection and the Use of MRSA-active Medication for Prophylaxis affect the Prognosis of Patients with Hematological Malignancies after CAR-T Infusion.
Topics: Anti-Bacterial Agents; Carbapenems; Hematologic Neoplasms; Humans; Methicillin-Resistant Staphylococcus aureus; Prognosis; Receptors, Chimeric Antigen | 2023 |
Effect of Antimicrobial Stewardship on Outcomes in Patients With Cancer or Undergoing Hematopoietic Stem Cell Transplantation.
Topics: Antimicrobial Stewardship; Carbapenems; Enterococcus; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Vancomycin | 2020 |
Comparative genomic analysis reveals a high prevalence of inter-species in vivo transfer of carbapenem-resistance plasmids in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Carbapenem-Resistant Enterobacteriaceae; Carbapenems; Child; Child, Preschool; Enterobacteriaceae Infections; Female; Gene Transfer, Horizontal; Genomics; Gram-Negative Bacteria; Hematologic Neoplasms; Humans; Infant; Male; Middle Aged; Plasmids; Prevalence; Retrospective Studies; Whole Genome Sequencing; Young Adult | 2020 |
Antimicrobial Stewardship in a Hematological Malignancy Unit: Carbapenem Reduction and Decreased Vancomycin-Resistant Enterococcus Infection.
Topics: Anti-Bacterial Agents; Antimicrobial Stewardship; Carbapenems; Gram-Positive Bacterial Infections; Hematologic Neoplasms; Humans; Methicillin-Resistant Staphylococcus aureus; Vancomycin | 2020 |
Antimicrobial utilization and antimicrobial resistance in patients with haematological malignancies in Japan: a multi-centre cross-sectional study.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cefepime; Cross-Sectional Studies; Drug Resistance, Bacterial; Drug Resistance, Multiple, Bacterial; Escherichia coli; Female; Hematologic Neoplasms; Humans; Japan; Male; Middle Aged; Piperacillin, Tazobactam Drug Combination; Young Adult | 2020 |
Impact of pre-transplant use of antibiotics on the graft-versus-host disease in adult patients with hematological malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Cefepime; Disease-Free Survival; Female; Glycopeptides; Graft vs Host Disease; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Young Adult | 2021 |
A change for the antibacterial treatment policy to decrease carbapenem consumption at a haematopoietic stem cell transplantation centre.
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Cross Infection; Febrile Neutropenia; Guidelines as Topic; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Penicillanic Acid; Piperacillin; Retrospective Studies; Tazobactam; Teicoplanin; Tertiary Care Centers; Treatment Outcome; Turkey; Vancomycin | 2017 |
Pseudomonas aeruginosa bacteraemia in patients with hematologic malignancies: risk factors, treatment and outcome.
Topics: Anti-Bacterial Agents; Bacteremia; Carbapenems; Case-Control Studies; Drug Resistance, Bacterial; Female; Fluoroquinolones; Hematologic Neoplasms; Hospitalization; Humans; Male; Middle Aged; Pseudomonas aeruginosa; Pseudomonas Infections; Risk Factors; Treatment Outcome | 2017 |
Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
Topics: Adult; Aged; Anti-Bacterial Agents; Carbapenems; Case-Control Studies; Cross Infection; Female; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Male; Middle Aged; Multivariate Analysis; Pneumonia; Prognosis; Stenotrophomonas maltophilia; Survival Analysis; Tertiary Care Centers; Trimethoprim, Sulfamethoxazole Drug Combination | 2018 |
Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancy.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Hematologic Neoplasms; Humans; Transplant Recipients | 2014 |
The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Hematologic Neoplasms; Humans; Immunocompromised Host; Risk Factors; Transplant Recipients; Treatment Outcome | 2014 |
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: an Italian multidisciplinary consensus statement.
Topics: Allografts; Carbapenems; Consensus; Drug Resistance; Hematologic Neoplasms; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Stem Cell Transplantation | 2015 |
Monitoring antibiotic-resistant enterobacteria faecal levels is helpful in predicting antibiotic susceptibility of bacteraemia isolates in patients with haematological malignancies.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Female; Hematologic Neoplasms; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neutropenia; Retrospective Studies; Young Adult | 2015 |
Mortality burden related to infection with carbapenem-resistant Gram-negative bacteria among haematological cancer patients: a retrospective cohort study.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Cohort Studies; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Humans; Male; Middle Aged; Retrospective Studies; Survival Analysis | 2015 |
Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Case-Control Studies; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; New York City; Prevalence; Risk Factors; Trimethoprim, Sulfamethoxazole Drug Combination; Young Adult | 2016 |
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey.
Topics: Antibiotic Prophylaxis; Bacteremia; Carbapenems; Cohort Studies; Drug Resistance, Microbial; Female; Hematologic Neoplasms; Humans; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Prognosis; Proportional Hazards Models; Prospective Studies; Registries | 2016 |
Carbapenem-resistant Klebsiella pneumoniae in high-risk haematological patients: factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Carbapenems; Community-Acquired Infections; Drug Resistance, Bacterial; Female; Hematologic Neoplasms; Hospitals, Teaching; Humans; Infection Control; Italy; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome | 2017 |
Clusters of infection due to metallo-β-lactamase-producing Pseudomonas aeruginosa in stem cell transplant and haematology units.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Brazil; Carbapenems; Cross Infection; DNA, Bacterial; Genotype; Hand Disinfection; Hematologic Neoplasms; Humans; Immunocompromised Host; Infection Control; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Stem Cell Transplantation; Transplantation | 2011 |
Control of an outbreak of carbapenem-resistant Pseudomonas aeruginosa in a haemato-oncology unit.
Topics: Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Hematologic Neoplasms; Humans; Incidence; Infection Control; Japan; Pseudomonas aeruginosa; Pseudomonas Infections | 2011 |
Emergence of carbapenem-resistant Enterobacteriaceae as causes of bloodstream infections in patients with hematologic malignancies.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactam Resistance; Carbapenems; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Genotype; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Phylogeny; Young Adult | 2013 |
Overgrowth of Enterococcus faecium in the feces of patients with hematologic malignancies.
Topics: Aminoglycosides; Ampicillin Resistance; Anti-Bacterial Agents; Bacterial Infections; Carbapenems; Cephalosporins; Colony Count, Microbial; Drug Resistance, Microbial; Enterococcus; Enterococcus faecium; Feces; Hematologic Neoplasms; Humans; Microbial Sensitivity Tests; Nitroimidazoles; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 1996 |